IL10 and neoplasm: Inhibits anti-tumor T-cell response, leading to progression of cancer through a modulatory effect on miR-21, which increases level of prostaglandin E2 and IL-10, although the exact mechanism is not clear.Stimulates expression of NF-κB gene through miRNA, which results in inflammation.